CN1118575A - 旋光异构化抑制剂 - Google Patents

旋光异构化抑制剂 Download PDF

Info

Publication number
CN1118575A
CN1118575A CN94191349A CN94191349A CN1118575A CN 1118575 A CN1118575 A CN 1118575A CN 94191349 A CN94191349 A CN 94191349A CN 94191349 A CN94191349 A CN 94191349A CN 1118575 A CN1118575 A CN 1118575A
Authority
CN
China
Prior art keywords
alkyl
optically active
alkenoyl
halogen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94191349A
Other languages
English (en)
Chinese (zh)
Inventor
福山真一
唐士纪嗣
中岛启一
幸田繁孝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of CN1118575A publication Critical patent/CN1118575A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN94191349A 1993-03-03 1994-02-21 旋光异构化抑制剂 Pending CN1118575A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4243093 1993-03-03
JP42430/93 1993-03-03

Publications (1)

Publication Number Publication Date
CN1118575A true CN1118575A (zh) 1996-03-13

Family

ID=12635853

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94191349A Pending CN1118575A (zh) 1993-03-03 1994-02-21 旋光异构化抑制剂

Country Status (10)

Country Link
EP (1) EP0687473A1 (enExample)
KR (1) KR960700753A (enExample)
CN (1) CN1118575A (enExample)
AU (1) AU6045994A (enExample)
CA (1) CA2157383A1 (enExample)
HU (1) HUT70950A (enExample)
IL (1) IL108810A0 (enExample)
TW (1) TW264390B (enExample)
WO (1) WO1994020143A1 (enExample)
ZA (1) ZA941209B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
AUPQ899400A0 (en) * 2000-07-26 2000-08-17 Csl Limited A method of stabilisation and compositions for use therein
KR101166394B1 (ko) * 2004-02-06 2012-07-23 추가이 세이야쿠 가부시키가이샤 Ｅｄ-71 제제
US20070292501A1 (en) * 2006-06-05 2007-12-20 Udell Ronald G Chewable soft gelatin capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56127309A (en) * 1980-03-11 1981-10-06 Dai Ichi Seiyaku Co Ltd Zeolite support for ascorbic acid
JPS5780328A (en) * 1980-11-06 1982-05-19 Sumitomo Chem Co Ltd Preparation of stable pharmaceutical preparation
JPS649285A (en) * 1987-06-30 1989-01-12 Shiseido Co Ltd Antioxidant
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Disubstituted 1,9-annelated [1,4] benzodiazepinone compounds, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
HU9402538D0 (en) 1994-11-28
WO1994020143A1 (fr) 1994-09-15
EP0687473A1 (en) 1995-12-20
KR960700753A (ko) 1996-02-24
IL108810A0 (en) 1994-06-24
ZA941209B (en) 1994-09-19
TW264390B (enExample) 1995-12-01
CA2157383A1 (en) 1994-09-15
AU6045994A (en) 1994-09-26
EP0687473A4 (enExample) 1996-01-24
HUT70950A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
CN1216047C (zh) 三环内酰胺和磺内酰胺衍生物和它们作为组蛋白脱乙酰基转移酶抑制剂的应用
TW202342454A (zh) 一種多功能化合物、其製備方法及其在醫藥上的應用
TW200906829A (en) 5,6-dihydro-1H-pyridin-2-one compounds
CN1237106A (zh) 含有4,5－环氧吗啡喃衍生物的稳定的药物组合物
RS58335B1 (sr) Konjugati kvetiapina sa masnom kiselinom, proces za njihovo dobijanje i njihova primena
JP7475055B2 (ja) （ｓ）－３－アミノ－４－（ジフルオロメチレニル）シクロペンタ－１－エン－１－カルボン酸の合成法
CN1694867A (zh) 口服固体药用晶体及治疗排尿困难的包含它的口服固体药
JP2017536416A (ja) フェノール酸ｔｒｐｖ１アゴニストのプロドラッグ
CN1186434A (zh) 含蛋白酶抑制剂和单酸甘油酯的药物组合物
JP5061134B2 (ja) ２−フェニルベンゾチアゾリン誘導体またはその塩類からなるκオピオイド受容体アゴニスト
CN1146413C (zh) 以对乙酰氨基酚为基础的注射用药物组合物
CN1128955A (zh) 经皮吸收制剂
CN1378447A (zh) 穿透细胞膜的靛类双吲哚衍生物的用途
CN1118575A (zh) 旋光异构化抑制剂
CN1037266C (zh) 喹啉衍生物的富马酸盐及其制法和其药物组合物
CN1438886A (zh) 滴眼液
CN1761665A (zh) 抗肿瘤效果增强剂和抗肿瘤剂
CN1138775C (zh) 乙酰胆碱增强剂及其用途
FR3122989A1 (fr) Nouveaux composes bifonctionnels de type protac ciblant pxr, leur procede de preparation et leur utilisation en therapeutique
CN1070190A (zh) 杂环取代的喹啉甲氧基苯乙酰胺
CN1849117A (zh) Hiv病毒的侵入抑制剂
CN1229339C (zh) 抑制血管生成和肿瘤生长的化合物，含有该化合物的药用制剂，以及该化合物的制药用途
CN1080113C (zh) 1,2,4－苯并三嗪氧化物的口服凝胶胶囊配方
JP4296345B2 (ja) ２−フェニルベンゾチアゾリン誘導体
WO2005061492A1 (ja) 含窒素複素環化合物およびそれらを有効成分とする薬剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication